LH - Laboratory Corp of America Holdings Stock Price, Fair Value and News

$224.58-2.64 (-1.16%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

LH RSI Chart

LH Valuation

Market Cap

19.1B

Price/Earnings (Trailing)

42.44

Price/Sales (Trailing)

1.53

Price/Free Cashflow

22.38

LH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LH Fundamentals

LH Revenue

Revenue (TTM)

12.5B

Rev. Growth (Yr)

6.17%

Rev. Growth (Qtr)

1.39%

LH Earnings

Earnings (TTM)

449.5M

Earnings Growth (Yr)

8.68%

Earnings Growth (Qtr)

-9.96%

LH Price Action

Last 7 days

4.1%

Last 30 days

0.5%

Last 90 days

9.6%

Trailing 12 Months

11.0%

LH Profitability

Operating Margin

28.00%

Return on Equity

5.61%

Return on Assets

2.69%

Free Cashflow Yield

4.47%

LH Financial Health

Current Ratio

0.88

Debt/Equity

0.38

Debt/Cashflow

0.45

LH Investor Care

Buy Backs (1Y)

5.23%

Diluted EPS (TTM)

5.38

LH Alerts

2 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	12.3B	12.5B	0	0
2023	13.0B	13.1B	13.3B	12.2B
2022	9.6B	8.7B	7.5B	10.6B
2021	18.1B	19.2B	22.3B	13.1B
2020	10.9B	10.2B	9.5B	16.8B
2019	11.4B	11.4B	11.5B	11.6B
2018	10.7B	11.1B	11.3B	11.3B
2017	9.6B	9.7B	9.9B	10.3B
2016	16.5B	16.7B	16.8B	16.8B
2015	6.4B	7.1B	7.9B	8.7B
2014	10.4B	10.4B	10.5B	10.6B
2013	5.7B	5.7B	5.8B	5.8B
2012	5.6B	5.6B	5.6B	5.7B
2011	5.2B	5.3B	5.5B	5.5B
2010	4.7B	4.8B	4.9B	5.0B
2009	0	0	4.6B	4.7B

Get all data in R, Python etc through our Historical Stock Data APIs

About Laboratory Corp of America Holdings

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

CEO	Mr. Adam H. Schechter
WEBSITE	labcorp.com
SECTOR	Healthcare
INDUSTRY	Diagnostics & Research
EMPLOYEES	60000

Laboratory Corp of America Holdings Frequently Asked Questions

What is the ticker symbol for Laboratory Corp of America Holdings? What does LH stand for in stocks?

LH is the stock ticker symbol of Laboratory Corp of America Holdings. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Laboratory Corp of America Holdings (LH)?

As of Wed Sep 18 2024, market cap of Laboratory Corp of America Holdings is 19.08 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LH stock?

You can check LH's fair value in chart for subscribers.

Is Laboratory Corp of America Holdings a good stock to buy?

The fair value guage provides a quick view whether LH is over valued or under valued. Whether Laboratory Corp of America Holdings is cheap or expensive depends on the assumptions which impact Laboratory Corp of America Holdings's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LH.

What is Laboratory Corp of America Holdings's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Sep 18 2024, LH's PE ratio (Price to Earnings) is 42.44 and Price to Sales (PS) ratio is 1.53. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Laboratory Corp of America Holdings's stock?

In the past 10 years, Laboratory Corp of America Holdings has provided 0.096 (multiply by 100 for percentage) rate of return.